AOD 9604

AOD9604:

Dosage, Benefits,

and Research Explained

AOD 9604 (Anti-Obesity Drug 9604) is a modified fragment of human growth hormone (HGH) specifically designed to stimulate fat metabolism and aid in weight loss without the growth-promoting effects of traditional HGH.

Unlike stimulants or thermogenic fat burners, AOD 9604 works by mimicking the natural fat-burning effects of HGH without affecting blood sugar or IGF-1 levels.

Sybthetic Peptide

CAS Number: 221231-10-3

Formula: C78H123N23O23S2

Purchase

Purchase from our preferred vendor: Project Zero

Use Case Common Dosage Frequency Duration Notes
Fat Loss & Weight Management 250-500 mcg 1-2x daily 8-12 weeks Best taken **in the morning or before workouts**.
Metabolism & Energy Boost 250-500 mcg 1-2x daily Ongoing Can be **combined with intermittent fasting**.
Joint & Cartilage Repair 300-600 mcg 1x daily 4-8 weeks Often **stacked with BPC-157 or TB-500**.

How It Works

AOD 9604 activates lipolysis (fat breakdown) and inhibits lipogenesis (fat storage) by:

✔ Targeting stubborn fat deposits – Encourages fat oxidation for energy.
✔ Increasing metabolic rate – Enhances calorie expenditure.
✔ Preserving lean muscle – Supports fat loss without muscle loss.
✔ Supporting joint & cartilage health – Aids in recovery from injuries.

AOD 9604 is one of the safest fat loss peptides, making it suitable for long-term use.

 

Research-Backed Benefits

1. Fat Loss & Metabolic Boost

  • Breaks down stored fat and enhances energy expenditure.
  • Targets stubborn fat areas (abdomen, thighs, hips).

2. Preserving Lean Muscle Mass

  • Prevents muscle loss during fat loss.
  • Enhances muscle tone & definition.

3. Joint & Cartilage Support

  • Accelerates tissue repair, making it beneficial for osteoarthritis & joint injuries.
  • Reduces inflammation & pain in joints.

4. No Impact on Blood Sugar or IGF-1 Levels

  • Unlike HGH, AOD 9604 does not increase insulin resistance or raise IGF-1 levels.

5. Safe & Well-Tolerated for Long-Term Use

  • Does not cause stimulant-related side effects.
  • Can be used long-term without hormonal imbalances.

 

Conclusion

AOD 9604 is a highly effective fat-burning & metabolic peptide that enhances weight loss, preserves muscle, and supports joint health. Unlike HGH, it specifically targets fat loss without affecting IGF-1 or insulin levels, making it a safe and powerful option for sustainable body recomposition.

How does AOD 9604 compare to HGH?

✔ AOD 9604 stimulates fat loss without increasing IGF-1 levels (unlike HGH).
✔ AOD 9604 does not affect blood sugar or insulin sensitivity.
✔ HGH has muscle-building effects, while AOD 9604 is purely fat-burning.

  • Fat loss & metabolism boost: Within 2-4 weeks.
  • Improved energy & workout performance: Within 1-2 weeks.
  • Joint & cartilage repair: 4-8 weeks of consistent use.

AOD 9604 is well-tolerated, but mild side effects may include:
✔ Mild nausea (at high doses)
✔ Temporary fatigue (rare)

Tip: If experiencing nausea, reduce the dose and take with food.

Yes! Some popular stacks for enhanced effects include:
✔ AOD 9604 + CJC-1295 + Ipamorelin → For fat loss & muscle preservation.
✔ AOD 9604 + BPC-157 + TB-500 → For joint repair & inflammation reduction.
✔ AOD 9604 + Semaglutide → For extreme fat loss & appetite control.

 

Referenced Citations

  1. Stier, H., et al. (2013). Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans. Journal of Endocrinology and Metabolism, 3(1-2), 7-15. [Online].
    Available: https://jofem.org/index.php/jofem/article/view/157/194
  2. Cox, H. D., et al. (2015). Detection and in vitro metabolism of AOD9604. Drug Testing and Analysis, 7(1), 31-38. [Online].
    Available: https://onlinelibrary.wiley.com/doi/pdf/10.1002/dta.1715
  3. SZieba, R., et al. (2014). Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model. Annals of Clinical & Laboratory Science, 45(4), 426-432. [Online].
    Available: http://www.annclinlabsci.org/content/45/4/426.full
  4. Valentino, M. A., et al. (2010). Obesity Pharmacotherapy: Current Perspectives and Future Directions. Clinical Pharmacology & Therapeutics, 87(6), 650-661. [Online].
    Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584306/
  5. RegenX Health. (2023). The Journey of AOD-9604: From Clinical Trials to Cosmetic Triumphs. [Online].
    Available:https://www.regenxhealth.com/post/the-journey-of-aod-9604-from-clinical-trials-to-cosmetic-triumphs
  6. Stier, H., et al. (2018). Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health. Journal of Endocrinology and Metabolism, 8(6), 107-116. [Online].
    Available: https://jofem.org/index.php/jofem/article/view/213/278
Scroll to Top